Clinical Trial Update: Giant Cell Arteritis and Anakinra Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anakinra for Giant cell arteritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: University Hospital, Caen | Conditions: Giant Cell Arteritis | Phase 3 | Status: TERMINATED